Xtrackers MSCI Emerging Markets UCITS ETF 1D is a equity ETF from Xtrackers tracking the MSCI Emerging Markets index through physical replication. Domiciled in Ireland and launched in 2021, the fund manages about 5.4 bn € and charges a TER of 0.18% — 18 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
Xtrackers MSCI Emerging Markets UCITS ETF 1D competes with 9 other products on the same index (MSCI Emerging Markets): it ranks 2nd by fund size and 5th by ongoing cost, with a TER of 0.18% against a group median of 0.18%. It has been listed since 2021, 5 years of track record.
On a €10,000 investment the TER costs 18 € a year. The cheapest of the group is Invesco MSCI Emerging Markets UCITS ETF USD at 0.09%, or 9 € on the same amount: a difference of 9 € every year, roughly 90 € over ten years before compounding.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 37.0% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Ireland, which determines the tax treatment of income received by the fund and the supervisory authority.
| Taiwan Semiconductor Manufacturing Co. Ltd. | 14.3% |
| Samsung Electronics Co Ltd | 7.7% |
| SK Hynix Inc | 6.5% |
| Tencent Holdings Ltd | 2.7% |
| Alibaba Group Holding Ltd | 2.1% |
| MediaTek Inc | 1.6% |
| Delta Electronics Inc | 1.2% |
| Hon Hai Precision Industry Co Ltd | 0.9% |
| XETRA | XEMD | EUR |
| London Stock Exchange | XEMD | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.